11-92353179-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001367949.2(FAT3):c.1067G>A(p.Cys356Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.00067 in 1,613,726 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.0012 ( 4 hom., cov: 32)
Exomes 𝑓: 0.00062 ( 12 hom. )
Consequence
FAT3
NM_001367949.2 missense
NM_001367949.2 missense
Scores
2
14
Clinical Significance
Conservation
PhyloP100: 4.14
Genes affected
FAT3 (HGNC:23112): (FAT atypical cadherin 3) Predicted to enable calcium ion binding activity. Predicted to be involved in cell-cell adhesion. Predicted to act upstream of or within several processes, including negative regulation of dendrite development; neuron migration; and retina layer formation. Predicted to be located in dendrite and plasma membrane. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0027287304).
BP6
Variant 11-92353179-G-A is Benign according to our data. Variant chr11-92353179-G-A is described in ClinVar as [Benign]. Clinvar id is 3044491.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.00118 (179/152258) while in subpopulation EAS AF= 0.0287 (148/5156). AF 95% confidence interval is 0.0249. There are 4 homozygotes in gnomad4. There are 90 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 4 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAT3 | NM_001367949.2 | c.1067G>A | p.Cys356Tyr | missense_variant | 2/28 | ENST00000525166.6 | NP_001354878.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAT3 | ENST00000525166.6 | c.1067G>A | p.Cys356Tyr | missense_variant | 2/28 | 5 | NM_001367949.2 | ENSP00000432586.2 | ||
FAT3 | ENST00000409404.6 | c.1067G>A | p.Cys356Tyr | missense_variant | 1/25 | 5 | ENSP00000387040.2 |
Frequencies
GnomAD3 genomes AF: 0.00116 AC: 177AN: 152140Hom.: 4 Cov.: 32
GnomAD3 genomes
AF:
AC:
177
AN:
152140
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00237 AC: 590AN: 248622Hom.: 10 AF XY: 0.00222 AC XY: 299AN XY: 134880
GnomAD3 exomes
AF:
AC:
590
AN:
248622
Hom.:
AF XY:
AC XY:
299
AN XY:
134880
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000617 AC: 902AN: 1461468Hom.: 12 Cov.: 31 AF XY: 0.000616 AC XY: 448AN XY: 727000
GnomAD4 exome
AF:
AC:
902
AN:
1461468
Hom.:
Cov.:
31
AF XY:
AC XY:
448
AN XY:
727000
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00118 AC: 179AN: 152258Hom.: 4 Cov.: 32 AF XY: 0.00121 AC XY: 90AN XY: 74436
GnomAD4 genome
AF:
AC:
179
AN:
152258
Hom.:
Cov.:
32
AF XY:
AC XY:
90
AN XY:
74436
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ExAC
AF:
AC:
271
Asia WGS
AF:
AC:
48
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
FAT3-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 28, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;.
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Vest4
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at